These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17702630)

  • 1. The economic impact of Parkinson's disease.
    Findley LJ
    Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S8-S12. PubMed ID: 17702630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
    Cubo E; Martínez Martin P; González M; Frades B;
    Neurologia; 2009; 24(1):15-23. PubMed ID: 19003550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of Parkinson's disease in eastern Europe: a Czech cohort study.
    Winter Y; von Campenhausen S; Brozova H; Skoupa J; Reese JP; Bötzel K; Eggert K; Oertel WH; Dodel R; Ruzicka E
    Parkinsonism Relat Disord; 2010 Jan; 16(1):51-6. PubMed ID: 19665915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
    Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD
    Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic impact of overactive bladder syndrome in six Western countries.
    Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
    BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of cardiovascular diseases in the United Kingdom.
    Luengo-Fernández R; Leal J; Gray A; Petersen S; Rayner M
    Heart; 2006 Oct; 92(10):1384-9. PubMed ID: 16702172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment.
    Weintraub D; Comella CL; Horn S
    Am J Manag Care; 2008 Mar; 14(2 Suppl):S40-8. PubMed ID: 18402507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost and quality aspects in the treatment of Parkinson's disease].
    Müller T; Dodel R; Fritze J
    Z Arztl Fortbild Qualitatssich; 2006; 100(4):291-5. PubMed ID: 16878798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of illness and care in Parkinson's disease: an evaluation in six countries.
    von Campenhausen S; Winter Y; Rodrigues e Silva A; Sampaio C; Ruzicka E; Barone P; Poewe W; Guekht A; Mateus C; Pfeiffer KP; Berger K; Skoupa J; Bötzel K; Geiger-Gritsch S; Siebert U; Balzer-Geldsetzer M; Oertel WH; Dodel R; Reese JP
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):180-91. PubMed ID: 20888737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The health burdens of Parkinson's disease.
    Chrischilles EA; Rubenstein LM; Voelker MD; Wallace RB; Rodnitzky RL
    Mov Disord; 1998 May; 13(3):406-13. PubMed ID: 9613729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indirect costs in idiopathic Parkinson's disease].
    Barth F; Baum B; Bremen D; Meuser T; Jost WH
    Fortschr Neurol Psychiatr; 2005 Apr; 73(4):187-91. PubMed ID: 15806436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of disease related to Parkinson's disease in Spain in the year 2000.
    Cubo E; Alvarez E; Morant C; de Pedro Cuesta J; Martínez Martín P; Génova R; Freire JM
    Mov Disord; 2005 Nov; 20(11):1481-7. PubMed ID: 16037922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the direct and indirect costs associated with Parkinson's disease.
    Rodríguez-Blázquez C; Forjaz MJ; Lizán L; Paz S; Martínez-Martín P
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):889-911. PubMed ID: 26511768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current and projected economic burden of Parkinson's disease in the United States.
    Kowal SL; Dall TM; Chakrabarti R; Storm MV; Jain A
    Mov Disord; 2013 Mar; 28(3):311-8. PubMed ID: 23436720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug and treatment costs in Parkinson's disease patients in Sweden.
    Lökk J; Borg S; Svensson J; Persson U; Ljunggren G
    Acta Neurol Scand; 2012 Feb; 125(2):142-7. PubMed ID: 21470194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology.
    Bickers DR; Lim HW; Margolis D; Weinstock MA; Goodman C; Faulkner E; Gould C; Gemmen E; Dall T; ;
    J Am Acad Dermatol; 2006 Sep; 55(3):490-500. PubMed ID: 16908356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the cost of Parkinson's disease.
    McCrone P; Allcock LM; Burn DJ
    Mov Disord; 2007 Apr; 22(6):804-12. PubMed ID: 17290462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Health-economic burden of Parkinson's disease in Portugal: a cohort study].
    Reese JP; Winter Y; Rosa MM; Rodrigues E Silva AM; von Campenhausen S; Freire R; Mateus C; Balzer-Geldsetzer M; Botzel K; Oertel WH; Dodel R; Sampaio C
    Rev Neurol; 2011 Mar; 52(5):264-74. PubMed ID: 21341221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic analysis of spa therapy in Parkinson's disease.
    Brefel-Courbon C; Desboeuf K; Thalamas C; Galitzky M; Senard JM; Rascol O; Montastruc JL
    Mov Disord; 2003 May; 18(5):578-84. PubMed ID: 12722173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.